AstraZeneca Vaccine Trials In Older Volunteers Published

AstraZeneca Vaccine Trials In Older Volunteers Published
AstraZeneca Vaccine Trials In Older Volunteers Published

Video: AstraZeneca Vaccine Trials In Older Volunteers Published

Video: Brazilian volunteer of AstraZeneca's COVID-19 vaccine trial dies; trials continue 2022, November
Anonim

Photo: ru.depositphotos.com Epidemiologists and virologists working for the pharmaceutical company AstraZenec reported that they have completed the second phase of testing a new vaccine AZD1222. Biologists and virologists from the National Institutes of Health of the United States of America and the University of Oxford in the UK were the creators of the drug, codenamed AZD1222, according to The Lancet. Interestingly, the SARS-CoV-2 virus vaccine was developed on the basis of the ChAdOx1-MERS vaccine, this drug was created to counteract the fever codenamed MERS. For the second phase of testing, 560 elderly British people were involved, and doctors have already reported that the tests were successful. The researchers believe it is an excellent achievement that older people have responded well to the vaccine. There were no particular discrepancies with the results shown by younger volunteers. The list of side effects from the new vaccine so far includes the following effects: slight dizziness and slight skin pigmentation at the puncture site. All volunteers who participated in the experiment developed the required amount of antibodies to be considered successful tests.

Image
Image

Popular by topic